Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania.
Division of Urology, University of Sao Paulo School of Medicine, Hospital das Clinicas, University of São Paulo School of Medicine, São Paulo, Brazil.
Am J Pathol. 2019 Apr;189(4):847-867. doi: 10.1016/j.ajpath.2018.12.013. Epub 2019 Jan 30.
Caveolins (CAVs) are structural proteins of caveolae that function as signaling platforms to regulate smooth muscle contraction. Loss of CAV protein expression is associated with impaired contraction in obstruction-induced bladder smooth muscle (BSM) hypertrophy. In this study, microarray analysis of bladder RNA revealed down-regulation of CAV1, CAV2, and CAV3 gene transcription in BSM from models of obstructive bladder disease in mice and humans. We identified and characterized regulatory regions responsible for CAV1, CAV2, and CAV3 gene expression in mice with obstruction-induced BSM hypertrophy, and in men with benign prostatic hyperplasia. DNA affinity chromatography and chromatin immunoprecipitation assays revealed a greater increase in binding of GATA-binding factor 6 (GATA-6) and NF-κB to their cognate binding motifs on CAV1, CAV2, and CAV3 promoters in obstructed BSM relative to that observed in control BSM. Knockout of NF-κB subunits, shRNA-mediated knockdown of GATA-6, or pharmacologic inhibition of GATA-6 and NF-κB in BSM increased CAV1, CAV2, and CAV3 transcription and promoter activity. Conversely, overexpression of GATA-6 decreased CAV2 and CAV3 transcription and promoter activity. Collectively, these data provide new insight into the mechanisms by which CAV gene expression is repressed in hypertrophied BSM in obstructive bladder disease.
窖蛋白(CAVs)是质膜凹陷的结构蛋白,作为信号平台调节平滑肌收缩。CAV 蛋白表达缺失与梗阻诱导的膀胱平滑肌(BSM)肥厚中收缩功能受损有关。在这项研究中,通过对膀胱 RNA 的微阵列分析,发现小鼠和人类梗阻性膀胱疾病模型的 BSM 中 CAV1、CAV2 和 CAV3 基因转录下调。我们鉴定并表征了与梗阻诱导的 BSM 肥厚以及男性良性前列腺增生相关的 CAV1、CAV2 和 CAV3 基因表达的调节区域。DNA 亲和层析和染色质免疫沉淀分析显示,与对照组 BSM 相比,在梗阻 BSM 中,GATA 结合因子 6(GATA-6)和 NF-κB 与其在 CAV1、CAV2 和 CAV3 启动子上的同源结合基序的结合增加。NF-κB 亚基敲除、BSM 中 GATA-6 的 shRNA 介导敲低或 GATA-6 和 NF-κB 的药理学抑制增加了 CAV1、CAV2 和 CAV3 的转录和启动子活性。相反,GATA-6 的过表达降低了 CAV2 和 CAV3 的转录和启动子活性。总的来说,这些数据为梗阻性膀胱疾病中肥厚 BSM 中 CAV 基因表达受抑制的机制提供了新的见解。